JPRN-UMIN000009275招募中2 期
PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC. - PhaseII study of maintenance S-1 after chemotherapy with platinium+pemetrexed in advanced nonsquamous NSCLC.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Interstitial pneumonia or pulmonary fibrosis on chest X-ray 2) History of serious drug allergy 3)Patients with active double cancer 4)Patients with pleural or pericardial effusion ,or ascites 5)Being treated with flucytosine. 6) History of serious infection 7)History of HBs antigen 8)Patients with significant complications a) Uncontrolled angina pectoris, myocardial infarction, heart failure within 3 months b)Uncontrolled diabetes or hypertension c)Current severe infection, or suspicious of severe infection d) Patients whose participation in the trial is judged to be inappropriate by the attending doctor. (e.g., ileus, bleeding tendency, diarrhea and varicella) 9 )Symptomatic brain metastases 10)Patients with pregnancy or lactation 11)patients whom it is judged to have difficulty in participation in study because of psychosis or neurologic disease 12)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
研究者
相似试验
尚未招募
2 期
Maintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRTLocally Advanced Unresectable Esophageal CancerNCT06598917China Medical University Hospital60
已完成
2 期
ESOX trialadenocarcinoma of the esophagogastric junctionJPRN-jRCTs051180192Watanabe Masayuki50
招募中
2 期
A phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in T3/T4a and/or lymph node-positive advanced adenocarcinoma of the esophagogastric junctioJPRN-UMIN000020815Cancer Institute Hospital, Gastroenterological Chemotherapy Department50
已完成
2 期
A phase II study of systemic chemotherapy with S-1 and Oxaliplatin followed by gastrectomy with D2 or D2 plus limited para-aortic lymph node dissection in HER2 negative advanced gastric or esophagogastric junction cancer with extensive lymph node metastasisGastric cancerJPRN-UMIN000027506Cancer Institute Hospital35
进行中(未招募)
2 期
SOX-D2 studyGastric CancerJPRN-jRCTs051180198Sano Takeshi35
